6942-ABIOMED Inc., part of Johnson & Johnson MedTech, is dedicated to advancing healthcare through innovative technologies that enhance patient outcomes. The company focuses on developing next-generation cardiac support systems, including the Impella heart pump, which are designed to be smarter, less invasive, and more personalized. With a commitment to cybersecurity and regulatory compliance, ABIOMED ensures that its medical devices are secure throughout their lifecycle. By leveraging expertise in both biology and technology, ABIOMED aims to transform the treatment of complex diseases and improve health for humanity.